https://www.selleckchem.com/pr....oducts/fenebrutinib-
the TNM stage) demonstrated satisfactory performance in predicting survival in patients with iCCA. Mutation-related signature and TMB were associated with prognosis in patients with iCCA. Our study provides a valuable prognostic predictor for determining outcomes in patients with iCCA. Mutation-related signature and TMB were associated with prognosis in patients with iCCA. Our study provides a valuable prognostic predictor for determining outcomes in patients with iCCA. Cervical cancer is a leading cancer and cause of prem
Like
Comment
Share
